Skip to main content

Table 1 Averaged area under the ROC curve (AUC) and coefficient of determination (R 2 probit ), as well standard deviations (between parenthesis), obtained from the testing sets in the 10 fold-crossvalidation analyses of time to first recurrence (TFR) and time to progression in the whole (TP), high risk (TPHiR) and low risk (TPLR) cohorts

From: Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

Model Criterion TFR TP TPHiR TPLR
   Whole series Whole series HiR tumors LR tumors
CPP AUC 0.62 (0.05) 0.76 (0.09) 0.57 (0.04) 0.45 (0.02)
  R 2 probit 0.031 (0.004) 0.054 (0.013) 0.151 (0.013) 0.0358 (0.0094)
SNPs AUC 0.55 (0.02) 0.58 (0.09) 0.56 (0.01) 0.55 (0.01)
  R 2 probit 0.010 (0.001) 0.001 (0.000) 0.009 (0.002) 0.0005 (0.0002)
CPP&SNPs AUC 0.61 (0.05) 0.76 (0.10) 0.57 (0.03) 0.47 (0.02)
  R 2 probit 0.041 (0.006) 0.050 (0.013) 0.155 (0.019) 0.0267 (0.0099)
  1. CPP clinico-pathological prognosticators